These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 9886898

  • 21. The endopeptidase activity and the activation by Cl- of angiotensin-converting enzyme is evolutionarily conserved: purification and properties of an an angiotensin-converting enzyme from the housefly, Musca domestica.
    Lamango NS, Sajid M, Isaac RE.
    Biochem J; 1996 Mar 01; 314 ( Pt 2)(Pt 2):639-46. PubMed ID: 8670080
    [Abstract] [Full Text] [Related]

  • 22. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active.
    Wei L, Alhenc-Gelas F, Corvol P, Clauser E.
    J Biol Chem; 1991 May 15; 266(14):9002-8. PubMed ID: 1851160
    [Abstract] [Full Text] [Related]

  • 23. Purification of angiotensin I-converting enzyme from human lung.
    Nishimura K, Yoshida N, Hiwada K, Ueda E, Kokubu T.
    Biochim Biophys Acta; 1977 Aug 11; 483(2):398-408. PubMed ID: 19071
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease.
    Petrie MC, Padmanabhan N, McDonald JE, Hillier C, Connell JM, McMurray JJ.
    J Am Coll Cardiol; 2001 Mar 15; 37(4):1056-61. PubMed ID: 11263608
    [Abstract] [Full Text] [Related]

  • 25. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
    Brooks RR, Miller KE, Jones SM, Burns RH, Huang CT.
    J Pharm Sci; 1990 May 15; 79(5):384-8. PubMed ID: 2161922
    [Abstract] [Full Text] [Related]

  • 26. Identification and properties of a peptidyl dipeptidase in the housefly, Musca domestica, that resembles mammalian angiotensin-converting enzyme.
    Lamango NS, Isaac RE.
    Biochem J; 1994 May 01; 299 ( Pt 3)(Pt 3):651-7. PubMed ID: 8192653
    [Abstract] [Full Text] [Related]

  • 27. A rat brain isozyme of angiotensin-converting enzyme. Unique specificity for amidated peptide substrates.
    Strittmatter SM, Thiele EA, Kapiloff MS, Snyder SH.
    J Biol Chem; 1985 Aug 15; 260(17):9825-32. PubMed ID: 2991265
    [Abstract] [Full Text] [Related]

  • 28. Biochemical properties of the angiotensin-converting-like enzyme from the leech Theromyzon tessulatum.
    Laurent V, Salzet M.
    Peptides; 1996 Aug 15; 17(5):737-45. PubMed ID: 8844761
    [Abstract] [Full Text] [Related]

  • 29. Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis.
    Rushworth CA, Guy JL, Turner AJ.
    FEBS J; 2008 Dec 15; 275(23):6033-42. PubMed ID: 19021774
    [Abstract] [Full Text] [Related]

  • 30. Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme.
    Araujo MC, Melo RL, Cesari MH, Juliano MA, Juliano L, Carmona AK.
    Biochemistry; 2000 Jul 25; 39(29):8519-25. PubMed ID: 10913258
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Purification and characterization of angiotensin converting enzyme 2 (ACE2) from murine model of mesangial cell in culture.
    Aragão DS, Cunha TS, Arita DY, Andrade MC, Fernandes AB, Watanabe IK, Mortara RA, Casarini DE.
    Int J Biol Macromol; 2011 Jul 01; 49(1):79-84. PubMed ID: 21470562
    [Abstract] [Full Text] [Related]

  • 33. Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances.
    Karahan F, Turkoglu V.
    Chem Biol Interact; 2021 Sep 25; 347():109604. PubMed ID: 34352275
    [Abstract] [Full Text] [Related]

  • 34. In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-ser-asp-lys-pro and angiotensin I hydrolysis.
    Junot C, Menard J, Gonzales MF, Michaud A, Corvol P, Ezan E.
    J Pharmacol Exp Ther; 1999 Jun 25; 289(3):1257-61. PubMed ID: 10336514
    [Abstract] [Full Text] [Related]

  • 35. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM, Zakora M, Otte J.
    J Dairy Res; 2006 May 25; 73(2):178-86. PubMed ID: 16476177
    [Abstract] [Full Text] [Related]

  • 36. Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade.
    Tom B, de Vries R, Saxena PR, Danser AH.
    Hypertension; 2001 Jul 25; 38(1):95-9. PubMed ID: 11463767
    [Abstract] [Full Text] [Related]

  • 37. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
    Hiwada K, Inoue Y, Kokubu T.
    Gen Pharmacol; 1990 Jul 25; 21(4):555-8. PubMed ID: 2165961
    [Abstract] [Full Text] [Related]

  • 38. Rat testicular angiotensin I converting enzyme: purification and comparison with rat pulmonary enzyme.
    Yamaguchi T, Hiratsuka M, Ikekita M, Kizuki K, Moriya H.
    Adv Exp Med Biol; 1986 Jul 25; 198 Pt A():461-7. PubMed ID: 3028065
    [Abstract] [Full Text] [Related]

  • 39. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdös EG.
    Hypertension; 1998 Apr 25; 31(4):912-7. PubMed ID: 9535414
    [Abstract] [Full Text] [Related]

  • 40. Mixed-type inhibition of pulmonary angiotensin I-converting enzyme by captopril, enalaprilat and ramiprilat.
    Baudin B, Bénéteau-Burnat B.
    J Enzyme Inhib; 1999 Apr 25; 14(6):447-56. PubMed ID: 10536878
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.